EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 60 / No 1 (January-March 2025) Radioprotection, 60 1 (2025) 65-75 References
Open Access
Issue
Radioprotection
Volume 60, Number 1, January-March 2025
Page(s) 65 - 75
DOI https://doi.org/10.1051/radiopro/2024034
Published online 14 March 2025
  • AAPM. 2008. The Measurement, Reporting, and Management of Radiation Dose in CT. American Association of Physicists in Medicine. Report No. 96. [Google Scholar]
  • Adeleye B, Chetty N. 2018. Radiation dose from 18F-FDG PET/CT procedures: Influence of specific CT model and protocols. Radioprotection 53 (2): 107–113. [CrossRef] [EDP Sciences] [Google Scholar]
  • Alameen S, Tamam N, Awadain S, Sulieman A, Alkhaldi L, Ben HA. 2021. Radiobiological risks in terms of effective dose and organ dose from 18F-FDG whole-body PET/CT procedures. Saudi J Biolog Sci 28 (10): 5947–5951. [CrossRef] [Google Scholar]
  • Alashban Y, Albedaiwi O, Shubayr N. 2023. Radiation dose assessment for nuclear medicine workers in Riyadh, Saudi Arabia. Radioprotection 58 (1): 25–29. [CrossRef] [EDP Sciences] [Google Scholar]
  • Alessio AM, Farrell MB, Fahey FH. 2015. Role of reference levels in nuclear medicine: a report of the SNMMI dose optimization task force. J Nucl Med 56 (12): 1960–1964. [CrossRef] [PubMed] [Google Scholar]
  • Andersson M, Eckerman K, Mattsson S. 2017a. Lifetime attributable risk as an alternative to effective dose to describe the risk of cancer for patients in diagnostic and therapeutic nuclear medicine. Phys Med Biol 62 (24): 9177–9188. [CrossRef] [PubMed] [Google Scholar]
  • Andersson M, Johansson L, Eckerman K, Mattsson S. 2017b. IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms. EJNMMI Res 7: 88. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Berberoglu K. 2019. External radiation exposure rate after 18F-FDG PET/CT examination. Radioprotection 54: 113–116. [CrossRef] [EDP Sciences] [Google Scholar]
  • Boellaard R, Delgado-Bolton R, Oyen, WJG, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, … Krause BJ. 2015. FDG PET/CT: EANM procedure guidelines for tumour imaging. Version 2.0. Eur J Nucl Med Molecular Imag 42 (2): 328–354. [CrossRef] [PubMed] [Google Scholar]
  • Bouchareb Y, Tag N, Sulaiman H, Al-Riyami K, Jawa Z, Al-Dhuhli H. 2023. Optimization of BMI-based images for overweight and obese patients — implications on image quality, quantification, and radiation dose in whole body 18F-FDG PET/CT imaging. Nucl Med Molec Imag 57: 180–193. [CrossRef] [PubMed] [Google Scholar]
  • Brenner DJ. 2012. We can do better than effective dose for estimating or comparing low-dose radiation risks. Ann ICRP 41(3–4): 124–128. [CrossRef] [PubMed] [Google Scholar]
  • Breustedt B, Giussani A, Noßke D. 2018. Internal dose assessments − concepts, models and uncertainties. Radiat Measurements. https://doi.org/10.1016/J.RADMEAS.2018.06.013 [Google Scholar]
  • Choi HJ, Jang JW, Shin W-G., Park H, Incerti S, Min CH. 2020. Development of integrated prompt gamma imaging and positron emission tomography system for in vivo 3-D dose verification: a Monte Carlo study. Phys Med Biol 65. https://doi.org/10.1088/1361-6560/ab857c [PubMed] [Google Scholar]
  • El-Galaly TC, Villa D, Gormsen LC, Baech J, Lo A, Cheah CY. 2018. FDG-PET/CT in the management of lymphomas: current status and future directions. J Int Med 284: 358–376. [CrossRef] [PubMed] [Google Scholar]
  • Fahey FH, Bom, HH-S, Chiti A, Choi YY, Huang G, Lassmann M, Laurin N, Mut F, Nuñez-Miller R, O’Keeffe D, Pradhan P, Scott AM, Song S, Soni N, Uchiyama M, Vargas L. 2016. Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 2—Current Standards and the Path Toward Global Standardization. J Nucl Med 57: 1148–1157. [CrossRef] [PubMed] [Google Scholar]
  • Grimes J, Celler A. 2014. Comparison of internal dose estimates obtained using organ-level, voxel S value, and Monte Carlo techniques. Med Phys 41. https://doi.org/10.1118/1.4892606 [PubMed] [Google Scholar]
  • Halid B, Karim, MKA, Sabarudin A, Bakar KA, Shariff ND. 2018. Assessment of lifetime attributable risk of stomach and colon cancer during abdominal CT examinations based on Monte Carlo simulation. IFMBE Proc 63: 455–459. [CrossRef] [Google Scholar]
  • Halpern BS, Dahlbom M, Quon A, Schiepers C, Waldherr C, Silverman DH, Ratib O, Czernin J. 2004. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. J Nucl Med 45. [Google Scholar]
  • Harrison JD, Balonov M, Martin CJ, Ortiz Lopez P, Menzel H-G, Simmonds JR, Smith-Bindman R, Wakeford R. 2016. Use of effective dose. Ann ICRP 45 (1): 215–224. [CrossRef] [PubMed] [Google Scholar]
  • Harun HH, Karim MKA, Abbas Z, Rahman MAA, Sabarudin A, Ng KH. 2020. Association of radiation doses and cancer risks from CT pulmonary angiography examinations in relation to body diameter. Diagnostics 10(9). https://doi.org/10.3390/diagnostics10090681 [Google Scholar]
  • Huang B, Law MW-M, Khong P-L. 2009. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology 251: 166–174. [CrossRef] [PubMed] [Google Scholar]
  • Huda W, He W. 2012. Estimating cancer risks to adults undergoing body CT examinations. Radiat Protect Dosimetry 150: 168–179. [CrossRef] [PubMed] [Google Scholar]
  • Huda W, Schoepf UJ, Abro JA, Mah E, Costello P. 2011. Radiation-related cancer risks in a clinical patient population undergoing cardiac CT. Am J Roentgenol 196: 159–165. [Google Scholar]
  • ICRP. 2007. The 2007 recommendations of the international commission on radiological protection. ICRP Publication 103, Ann ICRP 37 (2–4). [Google Scholar]
  • ICRP. 2008. Radiation dose to patients from radiopharmaceuticals. ICRP Publication 106, Ann ICRP 38 (1-2): 1–197. [Google Scholar]
  • ICRP. 2015. ICRP Publication 128: Radiation dose to patients from radiopharmaceuticals: A Compendium of current information related to frequently used substances. Ann ICRP 44, 7–321. [Google Scholar]
  • ICRP. 2021. Use of dose quantities in radiological protection. ICRP Publication 147 Ann ICRP 50: 9–82. [Google Scholar]
  • ICRP. 2022. Radiation detriment calculation methodology. ICRP Publication 152, Ann ICR 51(3). [Google Scholar]
  • Karim MKA, Hashim S, Bakar KA, Bradley DA, Ang WC, Bahrudin NA, Mhareb MHA. 2017. Estimation of radiation cancer risk in CT-KUB. Radiat Phys Chem 137: 130–134. [CrossRef] [Google Scholar]
  • Karim MKA, Hashim S, Sabarudin A, Bradley D, Bahruddin N. 2016. Evaluating organ dose and radiation risk of routine CT examinations in Johor Malaysia. UKM Journal Article 45 (4): 567–573. [Google Scholar]
  • Kessara A, Buyukcizmeci N, Gedik GK. 2023. Estimation of patient organ and whole-body doses in [18F-FDG] PET/CT SCAN. Radiat Protect Dosimetry 199 (1): 61–68. [CrossRef] [PubMed] [Google Scholar]
  • Khamwan K, Krisanachinda A, Pasawang P. 2010. The determination of patient dose from (18)F-FDG PET/CT examination. Radiat Protect Dosimetry 141 (1): 50–55. [CrossRef] [PubMed] [Google Scholar]
  • Koopman D, van Osch, JA.C., Jager PL, Tenbergen, CJ.A., Knollema S, Slump CH, van Dalen, JA. 2016. How to determine the FDG activity for tumour PET imaging that satisfies European guidelines. EJNMMI Phys 3: 22. [CrossRef] [PubMed] [Google Scholar]
  • Kwon HW, Kim JP, Lee HJ, Paeng JC, Lee JS, Cheon GJ, Lee DS, Chung J-K., Kang KW. 2016. Radiation dose from whole-body F-18 fluorodeoxyglucose positron emission tomography/computed tomography: nationwide survey in Korea. J Korean Med Sci 31(Suppl 1): S69. [CrossRef] [PubMed] [Google Scholar]
  • Li Y, Jiang L, Wang H, Cai H, Xiang Y, Li L. 2019. Effective radiation dose of 18F-FDG PET/CT: How much does diagnostic CT contribute. Radiat Protect Dosimetry 187: 183–190. [Google Scholar]
  • Lim H, Choi J, Kim J-H., Cheong H-K., Ha M. 2018. Estimation of cancer incidence and mortality risks attributed to diagnostic medical radiation exposure in Korea, 2013. J Korean Med Sci 33 (29). https://doi.org/10.3346/jkms.2018.33.e211 [Google Scholar]
  • Masoomi M, Al-Shammeri I, Al-Kandari L, Elrahman H, Alshammari, JM. 2020. Establishment of National DRL for CT in Hybrid Imaging Studies (The Second Phase of the National NM CT (PET) Dose Audit for Kuwait Population −2019). MedRxiv. https://doi.org/10.1101/2020.09.20.20198176 [Google Scholar]
  • Masoomi M, Al-Shammeri I, Al-Kandari L, Elrahman H, Al-Shammeri J. 2021. National Diagnostic Reference Level (DRL) for nuclear medicine computed tomography-positron emission tomography hybrid imaging studies for Kuwait population: second phase dose audit-2019. BJR|Open 3(1): 20210020. https://doi.org/10.1259/bjro.20210020 [Google Scholar]
  • National Research Council. 2006. BEIR VII Phase II: Health Risks from Exposure to Low Levels of Ionizing Radiation. National Academies Press. https://doi.org/10.17226/11340 [Google Scholar]
  • Murat H, Awang Kechik MM, Chew MT, Kamal I, Abdul Karim MK. 2024. Bibliometric review of optimization and image processing of positron emission tomography (PET) imaging system between 1981–2022. Curr Med Imag 20. https://doi.org/10.2174/0115734056282004240403042345 [Google Scholar]
  • Murat H, Karim M, Kechik M, Amer M, Razak H, Kamal I, Chew M. 2023. Internal dose assessment of lymphoma 18 F-FDG Positron Emission Tomography (PET) scan. J Phys: Conf Ser 2623: 012003. https://doi.org/10.1088/1742-6596/2623/1/012003 [CrossRef] [Google Scholar]
  • Quinn BT, Dauer Z, Pandit-Taskar N, Schöder H, Dauer, LT (2016). Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates. BMC Med Imag. https://doi.org/10.1186/S12880-016-0143-Y [Google Scholar]
  • Salah H, Mayhoub FH, Sulieman A, Abuzaid M, Al-Mohammed HI, Alkhorayef M, Bradley DA. 2020. Fluoro-D-glucose (18F-FDG) PET/CT and patient effective dose. Radiat Phys Chem 173: 108926. [CrossRef] [Google Scholar]
  • Sprinz C, Zanon M, Altmayer S, Watte G, Irion K, Marchiori E, Hochhegger B. 2018. Effect s of blood glucose level on 18F fluorodeoxyglucose (18F-FDG) uptake for PET/CT in normal organs: an analysis on 5623 patients. Sci Rep 8: 6–11. [CrossRef] [PubMed] [Google Scholar]
  • Velo P, Ismail MI, Mohandas KK, Kasilingam L. 2023. A new upper limit for effective dose in patient administered with 18F-FDG for PET/CT whole-body imaging with diagnostic CT parameters. J Med Imag Radiat Sci 54 (1): 43–50. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.